STOCK TITAN

CervoMed (CRVO) Schedule 13G: Manager-linked 750,000-share holding

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

CervoMed Inc. Schedule 13G filing reports that CVI Investments, Inc. and Heights Capital Management, Inc. together beneficially hold 750,000 shares of CervoMed common stock, representing 5.5% of the class. The filing references 13,526,233 Shares outstanding as of completion of the offering per the Prospectus Supplement dated June 22, 2026. Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and may be deemed to possess voting and dispositive power over the shares; both Reporting Persons disclaim beneficial ownership except for pecuniary interest. The submission is signed by Sarah Travis and includes a Limited Power of Attorney and a Joint Filing Agreement as exhibits.

Positive

  • None.

Negative

  • None.

Insights

Structured disclosure of beneficial ownership and manager authority.

The filing lists 750,000 shares and states 5.5% of the outstanding common stock, providing a clear ownership snapshot after the referenced offering. It expressly notes the manager-client relationship: Heights Capital Management, Inc. serves as investment manager to CVI Investments, Inc.

Key dependencies include the Limited Power of Attorney and the accuracy of the Prospectus Supplement's 13,526,233 Shares outstanding figure. Subsequent filings would show any changes in holdings or voting power.

Filing aligns with Schedule 13G passive/reporting conventions.

The statement follows Schedule 13G formats by reporting amount beneficially owned, percent of class (5.5%), and the voting/dispositive power breakdown. It attaches a Limited Power of Attorney and Joint Filing Agreement to support authority to file.

Material actionability is limited: the filing is informational under securities rules and does not indicate planned transactions. Future Form 13D/4 filings would be required if the purpose or control intent changes.

Shares beneficially owned 750,000 shares Amount reported for CVI Investments / Heights Capital
Percent of class 5.5% Percent beneficially owned as stated in the filing
Shares outstanding 13,526,233 shares Outstanding as of completion of the referenced offering per Prospectus Supplement dated June 22, 2026
CUSIP 15713L109 CUSIP for CervoMed common stock listed on cover
beneficially owned regulatory
"Amount beneficially owned: The information required by this Item 4(a) is set forth in Row 9"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 750,000.00"
Limited Power of Attorney legal
"Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney"
Schedule 13G regulatory
"This statement is filed by the entities listed below ... with respect to the shares of common stock"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does CVI Investments report in CervoMed (CRVO)?

CVI Investments and Heights Capital report 750,000 shares, equal to 5.5% of the class. The filing cites 13,526,233 Shares outstanding as of the referenced offering completion per the Prospectus Supplement dated June 22, 2026.

Who may exercise voting or dispositive power over these CRVO shares?

The filing states Heights Capital Management, Inc. is the investment manager to CVI Investments and may exercise the reported voting and dispositive powers. Both Reporting Persons disclaim beneficial ownership except for pecuniary interest.

What documents accompany the Schedule 13G for CRVO?

The Schedule 13G includes Exhibit 24, a Limited Power of Attorney, and Exhibit 99, a Joint Filing Agreement. These exhibits document filing authority and the joint filing arrangement among the Reporting Persons.

Does this filing indicate an intent to acquire control of CervoMed?

No specific change-of-control intent is stated. The filing reports passive beneficial ownership under Schedule 13G conventions; any shift toward control or active acquisition intent would typically trigger an updated filing such as a Form 13D.





15713L109

(CUSIP Number)
06/18/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G



CVI Investments, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Date:06/26/2026
Heights Capital Management, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary
Date:06/26/2026

Comments accompanying signature: Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney, a copy of which is attached as Exhibit 24 hereto.
Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION ________ ________ 24 Limited Power of Attorney 99 Joint Filing Agreement